Third-party lab testing: 8 independent Janoshik assays on file, covering 8 substances, most recent test 2024-08-21.
Peptide supplier identified through Janoshik analytical testing records.
pct.zone is listed as active. Discovered via Janoshik third-party lab testing.
| Substance | Measured purity | Test date |
|---|---|---|
| Artvigil-150 | not reported | 2024-08-21 |
| SOTRET NF 8MG | not reported | 2024-08-21 |
| Clomisign 100 Mg | not reported | 2024-08-16 |
| Telmaheal 80 | not reported | 2024-08-15 |
| Vidalista 5 | not reported | 2024-08-14 |
| Gabasign-600 | not reported | 2024-06-12 |
| Eutrig-hp 100001U | not reported | 2024-04-18 |
| Modvigil-200 | not reported | 2023-09-25 |
None of these 8 assays carry a purity number on the certificate. They confirm the substance was submitted and tested, which is not the same as a measured result and not the same as a failure.
| Status | Active |
|---|---|
| Independent assays on file | 8 |
| Certificates of analysis | Vendor states COAs are available |
| Vendor type | Research-use supplier |
pct.zone is listed as active and we hold 8 independent Janoshik assays on file. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. We hold 8 third-party Janoshik assays for pct.zone, covering 8 substances. The most recent is dated 2024-08-21.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Compare this vendor: pct.zone vs Saiyan Med.
Other reviewed vendors: Peak Peptides Australia Review, Peak Performance Labs Peptides Review, Penguin Peptides Review.